299 related articles for article (PubMed ID: 33441136)
21. Systems pharmacology-based approach to investigate the mechanisms of Danggui-Shaoyao-san prescription for treatment of Alzheimer's disease.
Wu Q; Chen Y; Gu Y; Fang S; Li W; Wang Q; Fang J; Cai C
BMC Complement Med Ther; 2020 Sep; 20(1):282. PubMed ID: 32948180
[TBL] [Abstract][Full Text] [Related]
22. Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.
Zhang M; Schmitt-Ulms G; Sato C; Xi Z; Zhang Y; Zhou Y; St George-Hyslop P; Rogaeva E
PLoS One; 2016; 11(12):e0168812. PubMed ID: 28005991
[TBL] [Abstract][Full Text] [Related]
23. Exploration of the mechanism of traditional Chinese medicine by AI approach using unsupervised machine learning for cellular functional similarity of compounds in heterogeneous networks, XiaoErFuPi granules as an example.
Guo F; Tang X; Zhang W; Wei J; Tang S; Wu H; Yang H
Pharmacol Res; 2020 Oct; 160():105077. PubMed ID: 32687952
[TBL] [Abstract][Full Text] [Related]
24. Pathway-based integration of multi-omics data reveals lipidomics alterations validated in an Alzheimer's disease mouse model and risk loci carriers.
Garcia-Segura ME; Durainayagam BR; Liggi S; Graça G; Jimenez B; Dehghan A; Tzoulaki I; Karaman I; Elliott P; Griffin JL
J Neurochem; 2023 Jan; 164(1):57-76. PubMed ID: 36326588
[TBL] [Abstract][Full Text] [Related]
25. Uncovering neuroinflammation-related modules and potential repurposing drugs for Alzheimer's disease through multi-omics data integrative analysis.
Li S; Lu C; Zhao Z; Lu D; Zheng G
Front Aging Neurosci; 2023; 15():1161405. PubMed ID: 37333458
[TBL] [Abstract][Full Text] [Related]
26. Gene networks and systems biology in Alzheimer's disease: Insights from multi-omics approaches.
Rahimzadeh N; Srinivasan SS; Zhang J; Swarup V
Alzheimers Dement; 2024 May; 20(5):3587-3605. PubMed ID: 38534018
[TBL] [Abstract][Full Text] [Related]
27. Single-cell-led drug repurposing for Alzheimer's disease.
Parolo S; Mariotti F; Bora P; Carboni L; Domenici E
Sci Rep; 2023 Jan; 13(1):222. PubMed ID: 36604493
[TBL] [Abstract][Full Text] [Related]
28. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
29. Unlocking the concealed targets using system biology mapping for Alzheimer's disease.
Joshi P; Kawade V; Dhulap S; Goel M
Pharmacol Rep; 2019 Dec; 71(6):1104-1107. PubMed ID: 31634797
[TBL] [Abstract][Full Text] [Related]
30. Sex specific molecular networks and key drivers of Alzheimer's disease.
Guo L; Cao J; Hou J; Li Y; Huang M; Zhu L; Zhang L; Lee Y; Duarte ML; Zhou X; Wang M; Liu CC; Martens Y; Chao M; Goate A; Bu G; Haroutunian V; Cai D; Zhang B
Mol Neurodegener; 2023 Jun; 18(1):39. PubMed ID: 37340466
[TBL] [Abstract][Full Text] [Related]
31. Metabolic and signalling network maps integration: application to cross-talk studies and omics data analysis in cancer.
Sompairac N; Modamio J; Barillot E; Fleming RMT; Zinovyev A; Kuperstein I
BMC Bioinformatics; 2019 Apr; 20(Suppl 4):140. PubMed ID: 30999838
[TBL] [Abstract][Full Text] [Related]
32. The promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer's disease.
Clark C; Rabl M; Dayon L; Popp J
Front Aging Neurosci; 2022; 14():1065904. PubMed ID: 36570537
[TBL] [Abstract][Full Text] [Related]
33. Alzheimer's disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?
Mullane K; Williams M
Biochem Pharmacol; 2020 Jul; 177():113945. PubMed ID: 32247851
[TBL] [Abstract][Full Text] [Related]
34. A Review of the Recent Advances in Alzheimer's Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics.
Hajjo R; Sabbah DA; Abusara OH; Al Bawab AQ
Diagnostics (Basel); 2022 Nov; 12(12):. PubMed ID: 36552984
[TBL] [Abstract][Full Text] [Related]
35. Bridging the Gap: Multi-Omics Profiling of Brain Tissue in Alzheimer's Disease and Older Controls in Multi-Ethnic Populations.
Reddy JS; Heath L; Vander Linden A; Allen M; de Paiva Lopes K; Seifar F; Wang E; Ma Y; Poehlman WL; Quicksall ZS; Runnels A; Wang Y; Duong DM; Yin L; Xu K; Modeste ES; Shantaraman A; Dammer EB; Ping L; Oatman SR; Scanlan J; Ho C; Carrasquillo MM; Atik M; Yepez G; Mitchell AO; Nguyen TT; Chen X; Marquez DX; Reddy H; Xiao H; Seshadri S; Mayeux R; Prokop S; Lee EB; Serrano GE; Beach TG; Teich AF; Haroutunian V; Fox EJ; Gearing M; Wingo A; Wingo T; Lah JJ; Levey AI; Dickson DW; Barnes LL; De Jager P; Zhang B; Bennett D; Seyfried NT; Greenwood AK; Ertekin-Taner N
bioRxiv; 2024 Apr; ():. PubMed ID: 38659743
[TBL] [Abstract][Full Text] [Related]
36. Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach.
Hu YS; Xin J; Hu Y; Zhang L; Wang J
Alzheimers Res Ther; 2017 Apr; 9(1):29. PubMed ID: 28446202
[TBL] [Abstract][Full Text] [Related]
37. Systems Biology Approaches to Understanding the Human Immune System.
Dhillon BK; Smith M; Baghela A; Lee AHY; Hancock REW
Front Immunol; 2020; 11():1683. PubMed ID: 32849587
[TBL] [Abstract][Full Text] [Related]
38. Network Pharmacology-Based Strategy to Investigate the Pharmacologic Mechanisms of Coptidis Rhizoma for the Treatment of Alzheimer's Disease.
Ye XW; Wang HL; Cheng SQ; Xia LJ; Xu XF; Li XR
Front Aging Neurosci; 2022; 14():890046. PubMed ID: 35795239
[TBL] [Abstract][Full Text] [Related]
39. Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot.
Hampel H; Lista S; Khachaturian ZS
Alzheimers Dement; 2012 Jul; 8(4):312-36. PubMed ID: 22748938
[TBL] [Abstract][Full Text] [Related]
40. ADAS-viewer: web-based application for integrative analysis of multi-omics data in Alzheimer's disease.
Han S; Shin J; Jung H; Ryu J; Minassie H; Nho K; Koh I; Lee Y
NPJ Syst Biol Appl; 2021 Mar; 7(1):18. PubMed ID: 33741983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
